Jim Omel

@IMFjimMYELOMA

Myeloma since 1997. Retired from Family Practice after SCT. Cancer research advocate with NCI, Alliance, CIBMTR, FDA, many other areas.

Joined November 2014

341Following

3KFollowers

Jim Omel@IMFjimMYELOMA · 1 h

What to Know About Treating Frail Elderly Patients With Multiple Myeloma medpagetoday.com/medical-journe…

IMFjimMYELOMA's tweet card. Challenging, especially because of the difference between promising trials and real-world patients

Jim Omel@IMFjimMYELOMA · 1 h

For Your Patients: Getting to Know the Options for Newly Diagnosed Multiple Myeloma medpagetoday.com/medical-journe…

IMFjimMYELOMA's tweet card. New drug regimens, with or without transplant, are improving quality of life, prolonging survival

Jim Omel@IMFjimMYELOMA · 2 h

New PDUFA date is October 23

DDaniel Auclair@AuclairDan · Jul 23

FDA extends review period for GSK’s Blenrep in multiple myeloma #mmsm za.investing.com/news/company-n…

Jim Omel@IMFjimMYELOMA · 2 h

This myeloma patient and research advocate hopes so too, @MyelomaTeacher Other countries are certainly approving Blenrep.

@@MyelomaTeacher - Cindy Chmielewski@MyelomaTeacher · Jul 23

Blenrep Combinations are approved in Canada. This myeloma patient and research advocate is still hopeful the @US_FDA will follow suit! #mmsm ca.gsk.com/en-ca/media/pr…

371

Jim Omel@IMFjimMYELOMA · 2 h

Cancer DNA Can Be Detected in the Bloodstream Up to Three Years Before Diagnosis, Study Suggests - smithsonianmag.com/smart-news/can… @smithsonianmag Sure beats bone marrow exams!

IMFjimMYELOMA's tweet card. For a few individuals, scientists found genetic material from cancerous tumors in blood samples taken years before they were diagnosed through traditional methods

160

Jim Omel@IMFjimMYELOMA · Jul 21

Two nice “memories from this day” (1)IMF Support Group Leaders retreat. (2)Three amigos when there really were three. Life evolves and races by. Make the most of every day God gives us. Help someone, encourage someone every day! @NorthTxMSG @VincentRK @MyelomaTeacher @IMFsupport

IMFjimMYELOMA's tweet image. Two nice “memories from this day” (1)IMF Support Group Leaders retreat. (2)Three amigos when there really were three. Life evolves and races by. Make the most of every day God gives us. Help someone, encourage someone every day! @NorthTxMSG @VincentRK @MyelomaTeacher @IMFsupport

480

Jim Omel@IMFjimMYELOMA · Jul 20

FDA Advisory Committee Rejects Blenrep Combo Therapies—But a Positive Vote is Possible for Myeloma Patients Seeking New Options healthtree.org//myeloma/commu….

IMFjimMYELOMA's tweet card. On July 17, most FDA committee advisors voted negatively on the approval of blenrep with bortezomib and dexamethasone and with pomalidomide and dexamethasone.

2.0K

Jim Omel Retweeted

Mohamad Mohty@Mohty_EBMT · Jul 17

DREAMM-7 marks a step forward in relapsed myeloma, with belantamab-based therapy showing powerful and sustained survival benefits! Congratulations ⁦@dra_v_hungria⁩ et al. ⁦@TheLancetOncol⁩ ⁦@TheIACH⁩ ⁦@COMyCongress⁩ ⁦@mvmateos⁩

6.0K

Jim Omel@IMFjimMYELOMA · Jul 18

What a travesty! What a loss for #myeloma pts! Let us choose between blurry vision or death by myeloma.

NNoopur Raje@NoopurRajeMD · Jul 18

Indeed a shocker! If a drug going against an anti CD38 antibody head to head in a phase III trial shows a survival benefit, a vote against it makes no sense! Toxicity is manageable with appropriate dose reductions and dose intensity! Bela has made a real difference to patients!

1.0K

Jim Omel@IMFjimMYELOMA · Jul 18

Bela works when CAR-T and bispecifics don’t. Let pts decide if TEMPORARY blurry vision is worth their life!

@@MyelomaTeacher - Cindy Chmielewski@MyelomaTeacher · Jul 17

“missed opportunity” - as a patient the “missed opportunity” would be the @FDA does NOT approve Belantamab - Let patients decide if they are willing to take the risk! You are putting patients at risk by not granting access. #mmsm

1.0K

Jim Omel Retweeted

Yelak Biru@NorthTxMSG · Jul 17

I agree... I prefer to have One more option. One more change. One more Hope! And working with my myeloma specialists and attending clinicians to manage the toxicity.

1.0K

Jim Omel@IMFjimMYELOMA · Jul 18

Myeloma Drug's Comeback Nixed by FDA Panel medpagetoday.com/hematologyonco… Nitpicking over trial inclusions and posing the wrong questions (about dose instead of effectiveness) robbed #mmsm patients of an extremely effective ADC. Myeloma pts will die if FDA adheres to this sad vote.

IMFjimMYELOMA's tweet card. Advisory committee says benefits of belantamab mafodotin don't outweigh risks

516

Jim Omel@IMFjimMYELOMA · Jul 15

New Imaging Method Tracks Multiple Myeloma Treatment Success insideprecisionmedicine.com/topics/oncolog… via @Inside_PM

IMFjimMYELOMA's tweet card. A new imaging method tracks whether a multiple myeloma treatment is working in single cancer cells, aiding personalized therapy choices.

436

Jim Omel@IMFjimMYELOMA · Jul 12

Elotuzumab Plus PVd May Be Effective in Relapsed, Refractory MM oncologynurseadvisor.com/news/multiple-…

$IMFjimMYELOMA's tweet card. Researchers sought to determine whether adding elotuzumab to PVd would be safe and effective in treating patients with relapsed or refractory MM.$

144

Jim Omel Retweeted

Rahul Banerjee, MD, FACP@RahulBanerjeeMD · Jun 29

👏 I saw an interesting anecdote and just looked up the reference. Literally before I was born, an oncologist very succinctly and elegantly summarized how we offer hope to our patients living with cancer... these words are still true today! pubmed.ncbi.nlm.nih.gov/18750361/

155

20.0K

Jim Omel@IMFjimMYELOMA · Jun 28

Outpatient step up doing would be welcomed by patients. #mmsm

GGoutham Sunny@medoncodoc · Jun 28

European consensus on outpatient administration of Teclistamab #mmsm doi.org/10.1111/ejh.14… @VincentRK @RahulBanerjeeMD @urvishahMD @bdermanmd @szusmani @End_myeloma @Myeloma_Doc @myelomamd @hadidisamir

497

Jim Omel Retweeted

@MyelomaTeacher - Cindy Chmielewski@MyelomaTeacher · Jun 29

All-Oral # Myeloma Combo: Mezigdomide + Tazemetostat or Trametinib | Paul ... youtu.be/iiwJdDgfuCU?fe… #mmsm #EHA25 #EHA2025 #PaulRichardson

706

Jim Omel@IMFjimMYELOMA · Jul 3

You are an inspiration to all of us @NorthTxMSG .

YYelak Biru@NorthTxMSG · Jul 1

✨ I’m honored to share my story published by BlackDoctor.org: “How I Beat a Deadly Cancer Nobody Thought I Could Survive.” At just 25, I received a multiple myeloma diagnosis and was given only a few years to live. But I refused to accept that prognosis. Over the past…

727

Jim Omel@IMFjimMYELOMA · Jul 3

And thank God that you did, @VincentRK !!

VVincent Rajkumar@VincentRK · Jul 1

30 years today since I first started my career @MayoClinic 30 years in Rochester, Minnesota

690

Jim Omel@IMFjimMYELOMA · Jul 3

FDA Greenlights Linvoseltamab in Relapsed/Refractory Multiple Myeloma targetedonc.com/view/fda-green… via @targetedonc A BCMA-targeted Bispecific.

496